XML 18 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share EARNINGS (LOSS) PER SHARE
Basic earnings per ordinary share is computed by dividing net earnings attributable to the Company's common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per ordinary share is computed by dividing net earnings attributable to the Company's common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.

The details of the earnings per share calculations for the three months ended March 31, 2020 and 2019 are as follows (in millions, except per share and per share amounts:

Three months ended March 31, 2020
Three months ended March 31, 2019 (1)
Net loss attributable to common shareholders$(268.9) $(74.3) 
Weighted-average number of ordinary shares outstanding - basic240,656,864  118,261,955  
Less dilutive effect of equity-based compensation and warrants—  —  
Weighted-average number of ordinary shares outstanding - diluted240,656,864  118,261,955  
Net income per share attributable to common shareholders
Basic$(1.12) $(0.63) 
Diluted(1.12) (0.63) 

(1)The Business Combination was accounted for as a reverse capitalization in accordance with U.S. GAAP. See Note 1 "Description of the Business". Accordingly, weighted-average shares outstanding for purposes of the earnings per share calculation have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination (1.0 Vertiv Holdings share to 118.261955 Vertiv Holdings Co shares).

Additional stock awards and warrants were outstanding during the three months ended March 31, 2020 but were not included in the computation of diluted earnings per common share because the effect would be anti-dilutive. Such anti-dilutive awards and warrants represented 5.4 million and 33.5 million shares, respectively, for the three months ended March 31, 2020.

Each warrant is exercisable for one share of Class A common stock at a price of $11.50 per share. No fractional shares will be issued upon exercise of the warrants and only whole warrants will trade. Warrants became exercisable 30 days after the Business Combination and will expire at 5:00 p.m., New York City time, five years after the completion of the Business Combination or earlier upon redemption or liquidation. Once the warrants become exercisable, the Company may redeem the outstanding warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, if and only if the last reported sale price of the Company’s Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sent the notice of redemption to the warrant holders.